ACHV
Achieve Life Sciences, Inc.
NASDAQ · Healthcare · Biotechnology · CA
$8.49
+2.17%Sep 3, 2026, 21:15 UTC
Achieve Life Sciences granted new hire inducement stock options for 315,000 shares and RSUs for 283,000 shares to seven new employees under its 2024 Equity Inducement Plan.
Source:Jul 31, 2026, 12:30 UTC
Achieve Life Sciences announced that its board approved granting stock options for 1,190,000 shares and RSUs for 125,000 shares of common stock to six new employees under its 2024 Equity Inducement Plan.
Source:Jun 22, 2026, 12:30 UTC
Achieve Life Sciences received a Complete Response Letter from the FDA for its cytisinicline NDA, citing manufacturing deficiencies at a third-party facility and incomplete labeling.
Jun 2, 2026, 00:00 UTC
Achieve Life Sciences appointed Jeff Farrow and Reid Waldman, M.D. as directors, effective May 29, 2026, each receiving stock options to purchase 47,250 shares vesting monthly over three years.